AQUILA BIOPHARMACEUTICALS INC (AQLA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AQUILA BIOPHARMACEUTICALS INC (AQLA)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dave K who wrote ()	5/15/2000 10:44:00 AM
From: AurumRabosa	Read Replies (1) of 45

Aquila Biopharmaceuticals Retains Financial Advisor To Evaluate Recent M&A Inquiries FRAMINGHAM, MA, May 15 /PRNewswire/ -- Aquila Biopharmaceuticals, Inc. (AQLA) today announced that it has engaged Adams, Harkness & Hill to provide financial advisory and investment banking services to assist the company in evaluating several merger and acquisition inquires recently received from other companies. "We are pleased that we have been contacted by several parties that are interested in our core immune modulation technologies, adjuvants and products. There is significant value in Aquila's two technology platforms and in our own and our partners product development pipelines," said Alison Taunton-Rigby, Ph.D. "We have retained Adams, Harkness & Hill to help us evaluate these opportunities and ensure that we will gain maximum value for our shareholders." biz.yahoo.com Anyone have a guess as to what we might expect for a takeover price?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next